277 related articles for article (PubMed ID: 23747143)
21. Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study.
Pichette V; Bonnardeaux A; Prudhomme L; Gagné M; Cardinal J; Ouimet D
Am J Kidney Dis; 1996 Jul; 28(1):105-14. PubMed ID: 8712204
[TBL] [Abstract][Full Text] [Related]
22. The prevalence of osteoporosis and the rate of bone loss in Korean adults: the Chungju metabolic disease cohort (CMC) study.
Lim Y; Jo K; Ha HS; Yim HW; Yoon KH; Lee WC; Son HY; Baek KH; Kang MI
Osteoporos Int; 2017 Apr; 28(4):1453-1459. PubMed ID: 28083665
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
[TBL] [Abstract][Full Text] [Related]
24. Osteoporosis and lung transplantation: a prospective study.
Spira A; Gutierrez C; Chaparro C; Hutcheon MA; Chan CK
Chest; 2000 Feb; 117(2):476-81. PubMed ID: 10669693
[TBL] [Abstract][Full Text] [Related]
25. High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy.
Yao S; McCarthy PL; Dunford LM; Roy DM; Brown K; Paplham P; Syta M; Lamonica D; Smiley S; Battiwalla M; Padmanabhan S; Hahn T
Bone Marrow Transplant; 2008 Feb; 41(4):393-8. PubMed ID: 17994116
[TBL] [Abstract][Full Text] [Related]
26. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study.
Marcén R; Caballero C; Pascual J; Teruel JL; Tenorio M; Ocaña J; Villafruela JJ; Burgos FJ; Fernández AM; Muriel A; Ortuño J
Transplantation; 2006 Mar; 81(6):826-31. PubMed ID: 16570003
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and patterns of bone loss in the first year after renal transplant in South East Asian patients.
Lim DS; Kee TY; Fook-Chong S; Zhang RF; Chandran M
Transplantation; 2011 Sep; 92(5):557-63. PubMed ID: 21832963
[TBL] [Abstract][Full Text] [Related]
28. Bone mineral density changes within 11 months of renal transplantation in Iranian patients.
Bayat N; Einollahi B; Pourfarzian V; Alishiri G; Nemati E; Bagheri N; Miri SM; Elizeii PK
Transplant Proc; 2007 May; 39(4):1039-43. PubMed ID: 17524886
[TBL] [Abstract][Full Text] [Related]
29. Bone mineral density in rural Thai adults living in Khon Kaen province.
Pongchaiyakul C; Rojroongwasinkul N; Chotmongkol R; Kosulwat V; Charoenkiatkul S; Rajatanavin R
J Med Assoc Thai; 2002 Feb; 85(2):235-44. PubMed ID: 12081125
[TBL] [Abstract][Full Text] [Related]
30. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases.
Bai XL; Liang TB; Wu LH; Li DL; Geng L; Wang WL; Shen Y; Zhang M; Zheng SS
Transplant Proc; 2007 Dec; 39(10):3182-5. PubMed ID: 18089348
[TBL] [Abstract][Full Text] [Related]
31. Bone mineral density in patients with interstitial lung disease.
Alhamad EH; Nadama R
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):151-9. PubMed ID: 26278695
[TBL] [Abstract][Full Text] [Related]
32. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
[TBL] [Abstract][Full Text] [Related]
33. Systematic review and meta-analysis for the association of bone mineral density and osteoporosis/osteopenia with vascular calcification in women.
Zhang Y; Feng B
Int J Rheum Dis; 2017 Feb; 20(2):154-160. PubMed ID: 27153243
[TBL] [Abstract][Full Text] [Related]
34. Age at transplant--one of the factors affecting bone mineral density in kidney recipients--a single-center retrospective study.
Huang WH; Lai PC
Ren Fail; 2011; 33(8):776-80. PubMed ID: 21777172
[TBL] [Abstract][Full Text] [Related]
35. Comparison of calcitonin versus calcitonin + resistance exercise as prophylaxis for osteoporosis in heart transplant recipients.
Braith RW; Magyari PM; Fulton MN; Lisor CF; Vogel SE; Hill JA; Aranda JM
Transplantation; 2006 Apr; 81(8):1191-5. PubMed ID: 16641607
[TBL] [Abstract][Full Text] [Related]
36. Inverse association of serum long-acting natriuretic peptide and bone mineral density in renal transplant recipients.
Hsu BG; Ho GJ; Lee CJ; Yang YC; Chen YC; Shih MH; Lee MC
Clin Transplant; 2012; 26(2):E105-10. PubMed ID: 22211802
[TBL] [Abstract][Full Text] [Related]
37. Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation.
D'Souza AB; Grigg AP; Szer J; Ebeling PR
Intern Med J; 2006 Sep; 36(9):600-3. PubMed ID: 16911552
[TBL] [Abstract][Full Text] [Related]
38. Osteopenia and osteoporosis in idiopathic benign positional vertigo.
Jeong SH; Choi SH; Kim JY; Koo JW; Kim HJ; Kim JS
Neurology; 2009 Mar; 72(12):1069-76. PubMed ID: 19307540
[TBL] [Abstract][Full Text] [Related]
39. Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate.
Bianda T; Linka A; Junga G; Brunner H; Steinert H; Kiowski W; Schmid C
Calcif Tissue Int; 2000 Aug; 67(2):116-21. PubMed ID: 10920215
[TBL] [Abstract][Full Text] [Related]
40. Weekly oral bisphosphonates over 2 years prevent bone loss in cardiac transplant patients.
Lange U; Classen K; Müller-Ladner U; Richter M
Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28940569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
